{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:30:46Z","timestamp":1648629046074},"reference-count":0,"publisher":"American Physiological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Renal Physiology"],"published-print":{"date-parts":[[1992,5,1]]},"abstract":"<jats:p> The presence of circulating inhibitors able to decrease the renal Na-K-adenosinetriphosphatase (ATPase) activity (natriuretic hormones) was postulated some 30 years ago. In the present work, the natriuretic inhibitor HgCl2 was selected as a model compound for the structural characterization of a possible natriuretic pathway for Na-K-ATPase modification. The structural effects of Na-K-ATPase inhibition by HgCl2 were assessed by trypsinolysis of the blocked enzyme in comparison with untreated preparations. The results show that inactivation of Na-K-ATPase by HgCl2 leads to the release of the alpha-subunit from the membrane preferentially in the E2 conformation but also in the E1 conformation. Apparently, HgCl2 weakens the membrane anchoring of the alpha-subunit, presumably by loosening the alpha-beta-subunit interaction. By this mechanism, the sensitivity of the Na-K-ATPase to extracellular drugs, hormones, and antibodies, as well as to intracellular proteases and other regulatory factors, could be altered. <\/jats:p>","DOI":"10.1152\/ajprenal.1992.262.5.f837","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T03:53:48Z","timestamp":1514001228000},"page":"F837-F842","source":"Crossref","is-referenced-by-count":1,"title":["Mercury weakens membrane anchoring of Na-K-ATPase"],"prefix":"10.1152","volume":"262","author":[{"given":"E.","family":"Imesch","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Geneva University Medical Center,Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moosmayer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Geneva University Medical Center,Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M.","family":"Anner","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Geneva University Medical Center,Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","container-title":["American Journal of Physiology-Renal Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajprenal.1992.262.5.F837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T16:16:50Z","timestamp":1567959410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajprenal.1992.262.5.F837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5,1]]}},"alternative-id":["10.1152\/ajprenal.1992.262.5.F837"],"URL":"https:\/\/doi.org\/10.1152\/ajprenal.1992.262.5.f837","relation":{},"ISSN":["1931-857X","1522-1466"],"issn-type":[{"value":"1931-857X","type":"print"},{"value":"1522-1466","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5,1]]}}}